Core Laboratories (CLB) Competitors

$10.41 +0.02 (+0.18%)

Closing price 09/25/2026 03:59 PM Eastern

Extended Trading

$10.39 -0.02 (-0.18%)

As of 09/25/2026 07:30 PM Eastern

CLB vs. PTEN, HAL, HP, MGY, and NBR

Should you buy Core Laboratories stock or one of its competitors? Core Laboratories's main competitors and comparable companies include Patterson-UTI Energy (PTEN), Halliburton (HAL), Helmerich & Payne (HP), Magnolia Oil & Gas (MGY), and Nabors Industries (NBR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "energy" sector.

How does Core Laboratories compare to Patterson-UTI Energy?

Core Laboratories (NYSE:CLB) and Patterson-UTI Energy (NASDAQ:PTEN) are both energy companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Core Laboratories currently has a consensus price target of $21.00, indicating a potential upside of 101.75%. Patterson-UTI Energy has a consensus price target of $13.25, indicating a potential upside of 21.45%. Given Core Laboratories' higher possible upside, research analysts clearly believe Core Laboratories is more favorable than Patterson-UTI Energy.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Patterson-UTI Energy	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53

Core Laboratories has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Patterson-UTI Energy has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

Core Laboratories has higher earnings, but lower revenue than Patterson-UTI Energy. Patterson-UTI Energy is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$519.18M	0.92	$29.67M	$0.56	18.59
Patterson-UTI Energy	$4.83B	0.86	-$93.64M	-$0.23	N/A

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Patterson-UTI Energy pays an annual dividend of $0.40 per share and has a dividend yield of 3.7%. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Patterson-UTI Energy pays out -173.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Patterson-UTI Energy is clearly the better dividend stock, given its higher yield and lower payout ratio.

Core Laboratories has a net margin of 5.10% compared to Patterson-UTI Energy's net margin of -1.92%. Core Laboratories' return on equity of 10.03% beat Patterson-UTI Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.10%	10.03%	4.71%
Patterson-UTI Energy	-1.92%	-1.68%	-0.98%

In the previous week, Patterson-UTI Energy had 6 more articles in the media than Core Laboratories. MarketBeat recorded 6 mentions for Patterson-UTI Energy and 0 mentions for Core Laboratories. Patterson-UTI Energy's average media sentiment score of 1.00 beat Core Laboratories' score of -0.27 indicating that Patterson-UTI Energy is being referred to more favorably in the news media.

Company	Overall Sentiment
Core Laboratories	Neutral
Patterson-UTI Energy	Positive

97.8% of Core Laboratories shares are owned by institutional investors. Comparatively, 97.9% of Patterson-UTI Energy shares are owned by institutional investors. 1.3% of Core Laboratories shares are owned by company insiders. Comparatively, 2.2% of Patterson-UTI Energy shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Core Laboratories and Patterson-UTI Energy tied by winning 9 of the 18 factors compared between the two stocks.

How does Core Laboratories compare to Halliburton?

Core Laboratories (NYSE:CLB) and Halliburton (NYSE:HAL) are both energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

Core Laboratories currently has a consensus target price of $21.00, indicating a potential upside of 101.75%. Halliburton has a consensus target price of $43.24, indicating a potential upside of 32.09%. Given Core Laboratories' higher possible upside, research analysts plainly believe Core Laboratories is more favorable than Halliburton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Halliburton	1 Sell rating(s)	6 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.68

In the previous week, Halliburton had 21 more articles in the media than Core Laboratories. MarketBeat recorded 21 mentions for Halliburton and 0 mentions for Core Laboratories. Halliburton's average media sentiment score of 0.76 beat Core Laboratories' score of -0.27 indicating that Halliburton is being referred to more favorably in the news media.

Company	Overall Sentiment
Core Laboratories	Neutral
Halliburton	Positive

Halliburton has higher revenue and earnings than Core Laboratories. Halliburton is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$519.18M	0.92	$29.67M	$0.56	18.59
Halliburton	$22.18B	1.23	$1.28B	$1.91	17.14

Halliburton has a net margin of 7.16% compared to Core Laboratories' net margin of 5.10%. Halliburton's return on equity of 18.71% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.10%	10.03%	4.71%
Halliburton	7.16%	18.71%	7.89%

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Halliburton pays an annual dividend of $0.68 per share and has a dividend yield of 2.1%. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Halliburton pays out 35.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Halliburton has increased its dividend for 4 consecutive years. Halliburton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

97.8% of Core Laboratories shares are owned by institutional investors. Comparatively, 85.2% of Halliburton shares are owned by institutional investors. 1.3% of Core Laboratories shares are owned by insiders. Comparatively, 0.6% of Halliburton shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Core Laboratories has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Halliburton has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

Summary

Halliburton beats Core Laboratories on 13 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Helmerich & Payne?

Helmerich & Payne (NYSE:HP) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

In the previous week, Helmerich & Payne had 3 more articles in the media than Core Laboratories. MarketBeat recorded 3 mentions for Helmerich & Payne and 0 mentions for Core Laboratories. Helmerich & Payne's average media sentiment score of 0.96 beat Core Laboratories' score of -0.27 indicating that Helmerich & Payne is being referred to more favorably in the media.

Company	Overall Sentiment
Helmerich & Payne	Positive
Core Laboratories	Neutral

96.1% of Helmerich & Payne shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 4.4% of Helmerich & Payne shares are owned by insiders. Comparatively, 1.3% of Core Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Core Laboratories has a net margin of 5.10% compared to Helmerich & Payne's net margin of -3.43%. Core Laboratories' return on equity of 10.03% beat Helmerich & Payne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Helmerich & Payne	-3.43%	-2.35%	-0.99%
Core Laboratories	5.10%	10.03%	4.71%

Helmerich & Payne has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Helmerich & Payne currently has a consensus target price of $43.10, suggesting a potential upside of 11.54%. Core Laboratories has a consensus target price of $21.00, suggesting a potential upside of 101.75%. Given Core Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Core Laboratories is more favorable than Helmerich & Payne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Helmerich & Payne	2 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.27
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Helmerich & Payne pays an annual dividend of $1.00 per share and has a dividend yield of 2.6%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Helmerich & Payne pays out -70.9% of its earnings in the form of a dividend. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Helmerich & Payne is clearly the better dividend stock, given its higher yield and lower payout ratio.

Core Laboratories has lower revenue, but higher earnings than Helmerich & Payne. Helmerich & Payne is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Helmerich & Payne	$4.00B	0.97	-$163.70M	-$1.41	N/A
Core Laboratories	$519.18M	0.92	$29.67M	$0.56	18.59

Summary

Core Laboratories beats Helmerich & Payne on 10 of the 18 factors compared between the two stocks.

How does Core Laboratories compare to Magnolia Oil & Gas?

Magnolia Oil & Gas (NYSE:MGY) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

94.7% of Magnolia Oil & Gas shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 0.9% of Magnolia Oil & Gas shares are owned by company insiders. Comparatively, 1.3% of Core Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Magnolia Oil & Gas had 12 more articles in the media than Core Laboratories. MarketBeat recorded 12 mentions for Magnolia Oil & Gas and 0 mentions for Core Laboratories. Magnolia Oil & Gas' average media sentiment score of 0.46 beat Core Laboratories' score of -0.27 indicating that Magnolia Oil & Gas is being referred to more favorably in the media.

Company	Overall Sentiment
Magnolia Oil & Gas	Neutral
Core Laboratories	Neutral

Magnolia Oil & Gas has higher revenue and earnings than Core Laboratories. Magnolia Oil & Gas is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Magnolia Oil & Gas	$1.31B	4.35	$325.25M	$2.28	10.57
Core Laboratories	$519.18M	0.92	$29.67M	$0.56	18.59

Magnolia Oil & Gas has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market.

Magnolia Oil & Gas pays an annual dividend of $0.72 per share and has a dividend yield of 3.0%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Magnolia Oil & Gas pays out 31.6% of its earnings in the form of a dividend. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Magnolia Oil & Gas has increased its dividend for 3 consecutive years. Magnolia Oil & Gas is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Magnolia Oil & Gas has a net margin of 28.77% compared to Core Laboratories' net margin of 5.10%. Magnolia Oil & Gas' return on equity of 21.04% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Magnolia Oil & Gas	28.77%	21.04%	14.46%
Core Laboratories	5.10%	10.03%	4.71%

Magnolia Oil & Gas currently has a consensus target price of $31.81, suggesting a potential upside of 31.96%. Core Laboratories has a consensus target price of $21.00, suggesting a potential upside of 101.75%. Given Core Laboratories' higher probable upside, analysts plainly believe Core Laboratories is more favorable than Magnolia Oil & Gas.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Magnolia Oil & Gas	0 Sell rating(s)	5 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.83
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Magnolia Oil & Gas beats Core Laboratories on 14 of the 20 factors compared between the two stocks.

How does Core Laboratories compare to Nabors Industries?

Nabors Industries (NYSE:NBR) and Core Laboratories (NYSE:CLB) are both small-cap energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Nabors Industries has higher revenue and earnings than Core Laboratories. Nabors Industries is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nabors Industries	$3.21B	0.41	$286.62M	$13.44	6.07
Core Laboratories	$519.18M	0.92	$29.67M	$0.56	18.59

81.9% of Nabors Industries shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 5.3% of Nabors Industries shares are owned by insiders. Comparatively, 1.3% of Core Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Nabors Industries presently has a consensus price target of $102.57, suggesting a potential upside of 25.69%. Core Laboratories has a consensus price target of $21.00, suggesting a potential upside of 101.75%. Given Core Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Core Laboratories is more favorable than Nabors Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nabors Industries	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Nabors Industries has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Core Laboratories has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

In the previous week, Nabors Industries had 1 more articles in the media than Core Laboratories. MarketBeat recorded 1 mentions for Nabors Industries and 0 mentions for Core Laboratories. Nabors Industries' average media sentiment score of 0.49 beat Core Laboratories' score of -0.27 indicating that Nabors Industries is being referred to more favorably in the media.

Company	Overall Sentiment
Nabors Industries	Neutral
Core Laboratories	Neutral

Nabors Industries has a net margin of 7.64% compared to Core Laboratories' net margin of 5.10%. Core Laboratories' return on equity of 10.03% beat Nabors Industries' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nabors Industries	7.64%	-7.06%	-1.45%
Core Laboratories	5.10%	10.03%	4.71%

Summary

Nabors Industries and Core Laboratories tied by winning 8 of the 16 factors compared between the two stocks.

Get Core Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLB vs. The Competition

Export

Metric	Core Laboratories	Energy Equipment & Services Industry	Energy Sector	NYSE Exchange
Market Cap	$477.62M	$3.55B	$9.79B	$23.01B
Dividend Yield	0.38%	13.42%	10.69%	3.68%
P/E Ratio	18.59	42.71	20.64	27.98
Price / Sales	0.92	29.96	509.83	21.73
Price / Cash	9.73	20.55	36.87	19.25
Price / Book	1.78	2.09	3.98	4.69
Net Income	$29.67M	$67.81M	$4.35B	$1.07B
7 Day Performance	-5.11%	-0.98%	-1.46%	-1.42%
1 Month Performance	-15.92%	-2.25%	-0.80%	-4.73%
1 Year Performance	-18.46%	35.22%	28.27%	7.73%

Core Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLB Core Laboratories	4.2626 of 5 stars	$10.41 +0.2%	$21.00 +101.7%	-18.5%	$477.62M	$519.18M	18.59	3,300
PTEN Patterson-UTI Energy	3.8751 of 5 stars	$11.14 -2.5%	$13.25 +18.9%	+95.5%	$4.25B	$4.67B	N/A	7,900
HAL Halliburton	4.9038 of 5 stars	$32.86 -1.6%	$43.24 +31.6%	+30.2%	$27.37B	$22.18B	17.20	46,000
HP Helmerich & Payne	2.8075 of 5 stars	$39.88 -1.0%	$43.10 +8.1%	+70.1%	$3.99B	$4.00B	N/A	6,200
MGY Magnolia Oil & Gas	4.6914 of 5 stars	$24.04 -0.9%	$31.79 +32.2%	-4.5%	$5.70B	$1.31B	10.54	262	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CLB) was last updated on 9/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Summary

How does Core Laboratories compare to Halliburton?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Summary

How does Core Laboratories compare to Nabors Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Do analysts prefer CLB or PTEN?

Which has more volatility & risk, CLB or PTEN?

Which has better valuation & earnings, CLB or PTEN?

Is CLB or PTEN a better dividend stock?

Is CLB or PTEN more profitable?

Does the media prefer CLB or PTEN?

Do institutionals & insiders have more ownership in CLB or PTEN?

Summary

How does Core Laboratories compare to Halliburton?

Do analysts rate CLB or HAL?

Does the media refer more to CLB or HAL?

Which has higher earnings and valuation, CLB or HAL?

Is CLB or HAL more profitable?

Is CLB or HAL a better dividend stock?

Do institutionals and insiders hold more shares of CLB or HAL?

Which has more risk and volatility, CLB or HAL?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Does the media refer more to HP or CLB?

Do institutionals and insiders hold more shares of HP or CLB?

Is HP or CLB more profitable?

Which has more volatility and risk, HP or CLB?

Do analysts prefer HP or CLB?

Is HP or CLB a better dividend stock?

Which has preferable valuation and earnings, HP or CLB?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Do institutionals & insiders hold more shares of MGY or CLB?

Does the media prefer MGY or CLB?

Which has better earnings & valuation, MGY or CLB?

Which has more risk & volatility, MGY or CLB?

Is MGY or CLB a better dividend stock?

Is MGY or CLB more profitable?

Do analysts prefer MGY or CLB?

Summary

How does Core Laboratories compare to Nabors Industries?

Which has stronger valuation & earnings, NBR or CLB?

Do insiders & institutionals have more ownership in NBR or CLB?

Do analysts rate NBR or CLB?

Which has more risk & volatility, NBR or CLB?

Does the media prefer NBR or CLB?

Is NBR or CLB more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools